Baystate Wealth Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
Baystate Wealth Management's ELV Position: Q4 2023 in Review
Baystate Wealth Management increased its Elevance Health (ELV) stake by 1.4% in Q4 2023, buying an estimated $462 and bringing the position to 75 shares worth $35.5K. The position accounts for ﹤0.01% of the portfolio, ranked #440.
Baystate Wealth Management first reported a position in ELV in Q1 2017 and has held it in 28 quarters since. The position peaked at $38K in Q4 2022. 1,658 funds tracked by Wall St. Rank hold ELV as of Q4 2023.
- Baystate Wealth Management held 75 shares of Elevance Health worth $35.5K as of Q4 2023.
- Baystate Wealth Management bought 1 Elevance Health share in Q4 2023, an estimated $462.
- Elevance Health made up ﹤0.01% of Baystate Wealth Management's portfolio in Q4 2023, its #440 holding.
- Baystate Wealth Management first reported a position in Elevance Health in Q1 2017 and has held it in 28 quarters since.
- Baystate Wealth Management's Elevance Health position peaked at $38K in Q4 2022.
- 1,658 funds tracked by Wall St. Rank held Elevance Health as of Q4 2023.
Based on Baystate Wealth Management's 13F filing for Q4 2023, filed 29 Jan 2024.